Cryoport, Inc.
Nasdaq · Pharmaceutical Preparations
Company Overview
A concise company profile alongside the latest public filing activity.
Cryoport provides temperature-controlled logistics and supply chain solutions for the life sciences industry, including biostorage, biologistics and informatics services used to support cell and gene therapies, reproductive medicine, and other biopharma applications.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| HANCOCK DANIEL MDirector | Sell | $1.50M | 74,379at $20.21 | Nov 9, 2026 |
| Sawicki Mark WChief Scientific Officer | Sell | $199K | 10,000at $19.93 | Nov 10, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable CYRX activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.